Pietro Puglisi
Managing partner
Pietro is Co-Founder and Managing Partner at Claris Ventures. A biomedical engineer with an MBA from Collège des Ingénieurs, he brings a background spanning life sciences management consulting and venture investing. He serves on the boards of several biotech companies and enjoys working at the intersection of rigorous science and patient impact. Education: MSc in Biomedical Engineering; MBA, Collège des Ingénieurs.
Pietro Puglisi
Managing Partner
Ciro Spedaliere
Managing partner
Ciro is Co-Founder and Managing Partner at Claris Ventures. His background spans venture capital, product management and strategic planning. He collaborates with universities and research centers on topics at the intersection of technology transfer and investing, and teaches venture capital in business schools. He also serves on the boards of several biotech companies. Education: MSc in Management Engineering; Venture Capital Executive Program at UC Berkeley’s Haas School of Business
Ciro Spedaliere
Managing Partner
Giulia Vestri
Partner
Giulia is Partner at Claris Ventures. A scientist by training (PhD in Immunology) with an Executive MBA, she brings a background across business development and strategic roles in the pharmaceutical and biotech sectors. Her work has focused on turning strong science into actionable plans across R&D and market contexts. Education: PhD in Immunology; Executive MBA, SDA Bocconi School of Management.
Giulia Vestri
Partner
Paolo Vigo
Investment Manager
Paolo is a Senior Associate at Claris Ventures. Trained as a mechanical engineer and an MBA graduate from the Collège des Ingénieurs, he works at the interface of data analysis and early-stage biotech. Before joining Claris, he held operational roles in biotech companies and conducted research at the Polytechnic University of Turin developing neural-network models for data analysis. Education: Mechanical Engineering; MBA, Collège des Ingénieurs.
Paolo Vigo
Investment Manager
Giuditta Magnifico
Senior Analyst
Giuditta is a Senior Analyst at Claris Ventures. A biomedical engineer by training, she has hands-on experience in research and development for the biotech sector, including data analysis, digital research infrastructure, and public–private collaborations for funding. Previously, her academic work focused on drug-delivery technologies for glioblastoma. Education: MSc in Biomedical Engineering (Politecnico di Milano, top honors); study experience at the American University of Science & Technology (Lebanon).
Giuditta Magnifico
Senior Analyst
Margherita Dematté
Analyst
Margherita is an Analyst at Claris Ventures. She brings a business background and hands-on experience in biopharma marketing and global strategic planning across oncology, rare diseases and neuroscience. Before joining Claris, she held operational roles within the pharmaceutical industry. Education: MBA candidate, SDA Bocconi School of Management; MSc in Management and BSc in Business Administration, Università Cattolica del Sacro Cuore.
Margherita Dematté
Analyst
Raffaele Troya
Finance & Administration Manager
Raffaele oversees finance and administration. He holds a Master’s degree in Corporate Finance and Financial Markets and previously gained experience in audit, post-deal accounting and financial analysis for large organizations, as well as exposure to early-stage investment processes. Education: MSc in Corporate Finance and Financial Markets, University of Turin.
Raffaele Troya
Finance & Administration Manager
Laura Irisi Ferro
Senior Advisor
Laura is a healthcare executive and entrepreneur with medical and business training (MD and MBA). Her career spans leadership across pharma and biotech, including founding and scaling ventures through international milestones. She has held multiple board and governance roles in life sciences and innovation. Education: MD; MBA, Bocconi University (Milan).
Laura Iris Ferro
Senior Advisor
Roberto De Ponti
Senior Advisor
Roberto is a pharmacist and EU Qualified Person with deep experience in pharmaceutical development, corporate ventures and strategic investments, particularly across oncology and rare diseases. His background covers licensing, alliances with academic and industry partners, and stewardship of development programs from preclinical stages onward.
Roberto De ponti
Senior Advisor
Manilo Marocco
Senior Advisor
Manilo is a finance professional with three decades across investment banking and private equity. His experience includes roles in European capital markets, fund management and seed/impact investing initiatives. Education: Economics, Turin.
Manilo Marocco
Senior Advisor
Cristina Tumiatti
indipendent Director
Cristina is an entrepreneur with extensive experience in international business development. She has served on governance bodies within the Italian innovation ecosystem and contributed to the launch and growth of investment platforms. Education: MSc in Business Administration (LIUC, Castellanza); MBA (SAA, Turin).
Cristina Tumiatti
Indipendent Director
Luca Melindo
Senior Advisor
Luca is a financial executive with broad experience in origination, evaluation and management of private equity transactions across industries, with a track record including development capital, buyouts and listings.